Condition

Solid Tumor Cancer clinical trials and research

• 29Clinical trials
• 8Countries

Newest Solid Tumor Cancer clinical trials

All recruiting trials (29)

• Urine samples from adults with solid cancers to explore chemistry linked to nearing end of life

  This study tests urine chemistry in adults with solid tumors to see if it reflects how close a patient is to death.

  Recruiting The Clatterbridge Cancer Centre NHS Foundation Trust · Liverpool, Merseyside · NCT07848997

• Tempus Open Link registry for cancer patients using Olivia platform

  This registry tests whether Olivia can securely enroll cancer patients and combine their health data from EHRs and patient-reported outcomes to build a large, de-identified dataset.

  Recruiting Tempus AI · Chicago, Illinois · NCT07756034

• Metronomic low-dose gemcitabine, mitomycin C, and thalidomide for advanced solid tumors

  This phase II trial tests a low-dose, continuously given combo of gemcitabine, mitomycin C, and thalidomide in adults with advanced solid tumors to see if it helps control the disease.

  Recruiting Phase 2 Sarcoma Oncology Research Center, LLC · Santa Monica, California · NCT07671534

• Imaging with 89Zr-DFO-YS5 to detect cancer

  This study tests a new PET radiotracer, 89Zr-DFO-YS5, to see if it can show cancer sites in adults with nerve sheath tumors, bladder cancer, or other solid tumors.

  Recruiting Phase 1 University of California, San Francisco · San Francisco, California · NCT07664397

• JL19001 Injection Alone or with Standard Therapy in Advanced Solid Tumors or Relapsed/Refractory B-Cell NHL

  This phase 1 trial tests JL19001 by itself or with standard treatment to see if it is safe and tolerable in adults with advanced solid tumors or relapsed/refractory B-cell non-Hodgkin lymphoma.

  Recruiting Phase 1 Jecho Biopharmaceuticals Co., Ltd. · Beijing, Beijing Municipality · NCT07603479

• Phase 1 dose-escalation and expansion test of IUAb190708 for advanced or recurrent solid tumors

  This trial tests IUAb190708, a new cytotoxic anti–PD‑L1 antibody given by IV, to see if it is safe and can kill tumors in adults with advanced or recurrent solid cancers.

  Recruiting at 6 sites Phase 1 ImmunoUrchin · Fuzhou, Fujian and 5 other locations · NCT07584954

• IL-22BP mRNA peptide therapy for advanced solid tumors

  A phase 1 study tests a new peptide-delivered IL-22BP mRNA treatment to see if it is safe and if it has any early signs of shrinking or stopping advanced solid tumors in adults.

  Recruiting Phase 1 West China Hospital · Chengdu, Sichuan · NCT07583654

• QLS5212 in people with advanced solid tumors

  This early-phase study tests different doses and schedules of QLS5212 given through IV in adults with unresectable or metastatic solid tumors to see if it is safe and tolerable.

  Recruiting Phase 1 Qilu Pharmaceutical Co., Ltd. · Taiyuan · NCT07467629

• IN10018 plus RNK08954 for KRASG12D-positive advanced solid tumors

  This trial will test whether combining IN10018 with RNK08954 can shrink tumors or control disease in people with KRASG12D-mutated locally advanced or metastatic solid tumors, with enrollment focused on pancreatic cancer.

  Recruiting Phase 1/2 InxMed (Shanghai) Co., Ltd. · Beijing, Beijing Municipality and 13 other locations · NCT07441174

• SYS6043 for adults with advanced or metastatic solid tumors

  This study will try SYS6043 in adults with advanced or metastatic solid tumors who have no standard treatment options to see if it is safe and might shrink tumors.

  Recruiting at 5 sites Phase 1 Conjupro Biotherapeutics, Inc. · Plantation, Florida and 4 other locations · NCT07424547

• First-in-human use of PLT012 in adults with advanced solid tumors

  This study will try different doses of an experimental drug called PLT012 given by IV every three weeks in adults with advanced solid tumors to find safe doses and see if it shrinks tumors.

  Recruiting at 4 sites Phase 1 Pilatus Biosciences Inc · Los Angeles, California and 3 other locations · NCT07337525

• WTX212A alone or combined with radiotherapy for advanced solid tumors

  This study will test whether WTX212A, given alone or together with radiotherapy, can help people with advanced solid tumors.

  Recruiting at 2 sites Phase 1 Sun Yat-sen University · Guangzhou, Guangdong and 1 other locations · NCT07269899

• Using methylation patterns to classify solid tumors

  This project will test whether DNA methylation profiling of tumor tissue can better classify and guide care for people with gliomas, endometrial, or endocrine tumors.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, BO · NCT07268066

• Using patient tumor tissue fragments to test drugs and guide treatment for previously treated cancers

  This will test whether growing tiny pieces of a patient's tumor and exposing them to different cancer drugs can help pick better treatments for people with advanced cancers who have already had prior therapy.

  Recruiting Phase 2 Qilu Hospital of Shandong University · Jinan, Shandong · NCT07264803

• AVZO-103 alone and with other treatments for advanced urothelial and other solid tumors

  This trial will test intravenous AVZO-103, alone and combined with other cancer drugs, to see if it is safe and helps adults with locally advanced or metastatic urothelial cancer or other solid tumors.

  Recruiting at 15 sites Phase 1/2 Avenzo Therapeutics, Inc. · San Francisco, California and 14 other locations · NCT07193511

• Super DC cell injections to prevent tumor recurrence after surgery.

  This trial will test whether injections of a Super DC vaccine can help prevent solid tumors from coming back in adults who have had their tumors completely removed.

  Recruiting Phase 1/2 Shanghai Cell Therapy Group Co.,Ltd · Shanghai · NCT07146672

• Pre-surgery focused radiation for spinal metastases.

  This trial will test whether short-course, focused radiation given before surgery can improve local tumor control and reduce pain and disability in adults with spinal metastases.

  Recruiting University Medical Center Goettingen · Göttingen · NCT07135817

• Distress screening and referral program for adults with newly diagnosed solid tumors

  This program will try a distress screening and referral process using the NCCN Distress Thermometer to help English- and Spanish-speaking adults newly diagnosed with solid tumors get connected to mental health support.

  Recruiting at 2 sites Memorial Sloan Kettering Cancer Center · New York, New York and 1 other locations · NCT07117461

• GV20-0251 treatment for adults with advanced solid tumors

  This study will test GV20-0251 to see if it helps adults with advanced solid tumors that have stopped responding to approved therapies.

  Recruiting at 3 sites Phase 1/2 GV20 Therapeutics · Beijing, Beijing Municipality and 2 other locations · NCT07070518

• AVZO-1418 alone and with other treatments for advanced epithelial solid tumors

  This trial will test whether intravenous AVZO-1418, alone or with other cancer drugs, is safe and helps adults with locally advanced or metastatic epithelial solid tumors, including some lung cancers.

  Recruiting at 27 sites Phase 1/2 Avenzo Therapeutics, Inc. · Gilbert, Arizona and 26 other locations · NCT07038343

• Combining Imatinib and Trametinib for KRAS-mutated Solid Tumors

  This study tests if combining two cancer drugs, imatinib and trametinib, can help people with hard-to-treat solid tumors that have KRAS mutations.

  Recruiting Phase 1 China Medical University Hospital · Taichung, Taichung · NCT06962254

• Evaluating MPD-1 for advanced solid tumors

  This study is testing a new drug called MPD-1 to see if it is safe and effective for people with advanced solid tumors that haven't responded to other treatments.

  Recruiting Phase 1 Pharosgen Co.,Ltd · Seoul · NCT06944457

• Evaluating AD1208 for advanced solid tumors

  This study is testing a new drug called AD1208 to see if it is safe and tolerable for people with advanced solid tumors.

  Recruiting at 3 sites Phase 1/2 Avelos Therapeutics Inc. · Seongnam-si, Gyeonggi-do and 2 other locations · NCT06911333

• Testing LXP1788 Injection for Advanced Solid Tumors

  This study is testing a new injection called LXP1788 to see if it can safely help people with advanced solid tumors that haven't responded to other treatments.

  Recruiting at 2 sites Phase 1 LaunXP Biomedical Co., Ltd. · Taichung and 1 other locations · NCT06883539

• Evaluating HLX43 with Serplulimab for Advanced Solid Tumors

  This study is testing a new combination of two cancer treatments, HLX43 and Serplulimab, to see if they can help people with advanced solid tumors feel better and improve their outcomes.

  Recruiting at 3 sites Phase 1/2 Shanghai Henlius Biotech · Hunan, Changsha and 2 other locations · NCT06848699

• Meal timing during cancer treatment for Alaska Native and American Indian patients

  This test will see if an 8-hour time-restricted eating schedule during neoadjuvant or adjuvant therapy helps Alaska Native and American Indian adults with rectal or certain breast cancers.

  Recruiting Fred Hutchinson Cancer Center · Anchorage, Alaska · NCT06802172

• Personalized vaccine targeting neoantigens for advanced solid tumors

  This study is testing a personalized vaccine made from patients' own cells to see if it can help people with advanced solid tumors, like head and neck cancer or non-small cell lung cancer, by targeting specific cancer markers.

  Recruiting Fudan University · Shanghai, Shanghai Municipality · NCT06682117

• Combining Lutathera® and Olaparib for treating recurrent solid tumors in children and adolescents

  This study is testing if combining Lutathera® with olaparib can help children and teenagers with hard-to-treat solid tumors that have certain receptors.

  Recruiting Phase 1/2 Fundación de investigación HM · Boadilla del Monte, Madrid · NCT06607692

• Using blood tests to assess early treatment response in cancer patients

  This study is testing if blood tests that look for cancer DNA can help doctors see how well treatment is working for patients with different types of solid tumors.

  Recruiting Washington University School of Medicine · St Louis, Missouri · NCT04354064

Related topics

Quick answers

How many Solid Tumor Cancer clinical trials are recruiting right now?

29, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 8 countries. The most sites are in China (12 trials), United States (10 trials), Taiwan (2 trials), South Korea (2 trials), Italy (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 11, Phase 1/2: 8, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →